Clinically actionable genetic findings by exome sequencing performed for therapeutic purposes in children with very-high risk cancer included the MAPPYACTS study

Tiphaine Adamde Beaumais, Yahia Adnani, Léa Guerrini-Rousseau, Samuel Abbou, Cécile Acquaviva-Bourdain, Pablo Berlanga, Adeline Bonnard, Gaelle Bougeard, Franck Bourdeaut, Nelly Burnichon, Sandrine Caputo, Alain Carrié, Olivier Caron, Hélène Cavé, Albain Chansavang, Nadège Corradini, Sophie Cotteret, Philippe Denizeau, Alice Fievet, Mathilde Filser, Thierry Frébourg, Marion Gauthier-Villars, Birgit Geoerger, Nadim Hamzaoui, Edwige Kasper, Florence Kyndt, Ludovic Lacroix, Jessica Le Gall, Julien Masliah-Planchon, Laurence Pacot, Cécile Pagan, Mélanie Pages, Béatrice Parfait, Eric Pasmant, Gaelle Pierron, Pascale Richard, Nathalie Roux-Buisson, Cécile Saint-Martin, Hela Sassi, Gudrun Schleiermacher, Renaud Touraine, Nancy Uhrhammer, Dominique Vidaud, Laurence Brugières, Gilles Vassal, Etienne Rouleau, Yoann Vial, Lisa Golmard, Odile Cabaret

Open source

DOI
10.1016/j.ejca.2026.117449
Published
2026-11
Container
European Journal of Cancer
Publisher
Elsevier BV
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.ejca.2026.117449,
  title = {Clinically actionable genetic findings by exome sequencing performed for therapeutic purposes in children with very-high risk cancer included the MAPPYACTS study},
  author = {Tiphaine Adamde Beaumais and Yahia Adnani and Léa Guerrini-Rousseau and Samuel Abbou and Cécile Acquaviva-Bourdain and Pablo Berlanga and Adeline Bonnard and Gaelle Bougeard and Franck Bourdeaut and Nelly Burnichon and Sandrine Caputo and Alain Carrié and Olivier Caron and Hélène Cavé and Albain Chansavang and Nadège Corradini and Sophie Cotteret and Philippe Denizeau and Alice Fievet and Mathilde Filser and Thierry Frébourg and Marion Gauthier-Villars and Birgit Geoerger and Nadim Hamzaoui and Edwige Kasper and Florence Kyndt and Ludovic Lacroix and Jessica Le Gall and Julien Masliah-Planchon and Laurence Pacot and Cécile Pagan and Mélanie Pages and Béatrice Parfait and Eric Pasmant and Gaelle Pierron and Pascale Richard and Nathalie Roux-Buisson and Cécile Saint-Martin and Hela Sassi and Gudrun Schleiermacher and Renaud Touraine and Nancy Uhrhammer and Dominique Vidaud and Laurence Brugières and Gilles Vassal and Etienne Rouleau and Yoann Vial and Lisa Golmard and Odile Cabaret},
  year = {2026},
  journal = {European Journal of Cancer},
  doi = {10.1016/j.ejca.2026.117449},
  url = {https://doi.org/10.1016/j.ejca.2026.117449}
}

RIS

TY  - JOUR
TI  - Clinically actionable genetic findings by exome sequencing performed for therapeutic purposes in children with very-high risk cancer included the MAPPYACTS study
AU  - Tiphaine Adamde Beaumais
AU  - Yahia Adnani
AU  - Léa Guerrini-Rousseau
AU  - Samuel Abbou
AU  - Cécile Acquaviva-Bourdain
AU  - Pablo Berlanga
AU  - Adeline Bonnard
AU  - Gaelle Bougeard
AU  - Franck Bourdeaut
AU  - Nelly Burnichon
AU  - Sandrine Caputo
AU  - Alain Carrié
AU  - Olivier Caron
AU  - Hélène Cavé
AU  - Albain Chansavang
AU  - Nadège Corradini
AU  - Sophie Cotteret
AU  - Philippe Denizeau
AU  - Alice Fievet
AU  - Mathilde Filser
AU  - Thierry Frébourg
AU  - Marion Gauthier-Villars
AU  - Birgit Geoerger
AU  - Nadim Hamzaoui
AU  - Edwige Kasper
AU  - Florence Kyndt
AU  - Ludovic Lacroix
AU  - Jessica Le Gall
AU  - Julien Masliah-Planchon
AU  - Laurence Pacot
AU  - Cécile Pagan
AU  - Mélanie Pages
AU  - Béatrice Parfait
AU  - Eric Pasmant
AU  - Gaelle Pierron
AU  - Pascale Richard
AU  - Nathalie Roux-Buisson
AU  - Cécile Saint-Martin
AU  - Hela Sassi
AU  - Gudrun Schleiermacher
AU  - Renaud Touraine
AU  - Nancy Uhrhammer
AU  - Dominique Vidaud
AU  - Laurence Brugières
AU  - Gilles Vassal
AU  - Etienne Rouleau
AU  - Yoann Vial
AU  - Lisa Golmard
AU  - Odile Cabaret
PY  - 2026
JO  - European Journal of Cancer
DO  - 10.1016/j.ejca.2026.117449
UR  - https://doi.org/10.1016/j.ejca.2026.117449
ER  - 

APA

Beaumais, T. A., Adnani, Y., Guerrini-Rousseau, L., Abbou, S., Acquaviva-Bourdain, C., Berlanga, P., Bonnard, A., Bougeard, G., Bourdeaut, F., Burnichon, N., Caputo, S., Carrié, A., Caron, O., Cavé, H., Chansavang, A., Corradini, N., Cotteret, S., Denizeau, P., Fievet, A., Filser, M., Frébourg, T., Gauthier-Villars, M., Geoerger, B., Hamzaoui, N., Kasper, E., Kyndt, F., Lacroix, L., Gall, J. L., Masliah-Planchon, J., Pacot, L., Pagan, C., Pages, M., Parfait, B., Pasmant, E., Pierron, G., Richard, P., Roux-Buisson, N., Saint-Martin, C., Sassi, H., Schleiermacher, G., Touraine, R., Uhrhammer, N., Vidaud, D., Brugières, L., Vassal, G., Rouleau, E., Vial, Y., Golmard, L., & Cabaret, O. (2026). Clinically actionable genetic findings by exome sequencing performed for therapeutic purposes in children with very-high risk cancer included the MAPPYACTS study. European Journal of Cancer. https://doi.org/10.1016/j.ejca.2026.117449

Source records